Zepbound

Zepbound® contains the same active ingredient as certain tirzepatide-based medications. It is a once-weekly, dual-action GLP-1/GIP receptor agonist approved by the FDA to support weight management for adults with obesity, or for adults who are overweight and also have a weight-related medical condition - alongside diet and physical activity.

Zepbound® is taken as a once-weekly injection under the skin. It can be used at any time of day, with or without food, and should be taken on the same day each week when possible. Your healthcare provider will guide you on how to use the injection and may adjust your dose over time based on your response and tolerability.

• Injected under the skin (abdomen, thigh, or upper arm)
• Taken once weekly on a consistent schedule
• Can be used with or without meals
• Injection sites should be rotated regularly
• Dose adjustments are managed by a healthcare provider

Zepbound® can cause side effects, most commonly related to the digestive system. These may occur more often when starting treatment or after dose adjustments. It is important to understand both common reactions and symptoms that may require prompt medical attention.

• Common: nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite
• Other possible: fatigue, reflux symptoms, injection site reactions
• Risk of low blood sugar may increase when used with certain diabetes medications
• Seek urgent care for severe abdominal pain, which may indicate pancreatitis
• Contact a provider immediately for symptoms such as a lump in the neck or trouble swallowing (possible thyroid tumor risk)

For detailed information see Important Safety Information and Prescribing Information

Zepbound® can be taken with or without food. Because it is injected under the skin, meals do not affect how it is administered. Choosing a consistent weekly time that fits your routine can help you stay on track with treatment.

• No need to coordinate with meals
• Can be taken at any time of day
• Consistency week to week is important
• Adjust timing if needed with provider guidance

If you miss a dose, what to do depends on how much time has passed. Acting within a certain timeframe may allow you to take the missed dose, but if too much time has passed, you should skip it.

• Take the dose if within the allowed window
• Skip if your next dose is too close
• Do not take two doses at once
• Continue your regular weekly schedule

Follow the Medication Guide or your provider’s instructions for exact timing.

Yes, you can change your dosing day if needed, but spacing between doses should be maintained. This helps reduce the risk of taking doses too close together.

• Ensure enough time between doses
• Choose a consistent new day
• Avoid overlapping injections
• Confirm changes with your provider if unsure

Your provider can guide you if your schedule changes.

Zepbound® is injected under the skin in specific areas. Rotating injection sites helps reduce irritation and supports consistent absorption.

• Common areas: abdomen, thigh, upper arm
• Rotate injection sites weekly
• Avoid irritated or damaged skin
• Use different spots within the same area if needed

Zepbound® may be used with other medications, but combining treatments can increase certain risks. Your provider will guide how to use them together safely.

• Higher risk of low blood sugar with insulin or sulfonylureas
• Dose adjustments may be needed
• Monitor for symptoms like dizziness or sweating
• Inform your provider about all medications

Always follow your provider’s instructions and report symptoms promptly.

Zepbound® may affect how oral contraceptives are absorbed, especially when starting treatment or increasing the dose. This could reduce effectiveness.

• Consider non-oral contraceptive methods
• Or add a barrier method temporarily
• Discuss options with your provider

Your provider can help you choose a suitable contraceptive plan.

Zepbound® should only be used if it has been stored correctly and appears normal. Improper storage may affect safety and effectiveness.

• Do not use if frozen
• Avoid use if exposed to incorrect temperatures
• Do not use if cloudy or discolored
• Ask your pharmacist or provider if unsure

When in doubt, replace the medication.

Zepbound® is not specifically labeled as impairing driving, but some symptoms may affect your ability to stay alert. It is important to understand how you respond to treatment.

• Be cautious if you feel dizzy or unwell
• Low blood sugar can affect focus
• Monitor your response after starting or adjusting treatment
• Avoid driving if you do not feel fully alert

There is no specific instruction in the prescribing information about alcohol use. However, alcohol can affect your overall health and treatment plan.

• Alcohol may influence blood sugar and appetite
• Effects vary depending on amount and timing
• Monitor how your body responds

Getting Zepbound® through US Quick Health starts with an online medical evaluation. A licensed provider reviews your health information and determines whether treatment is appropriate.

• Complete a consultation or questionnaire
• Provider evaluates your eligibility
• Prescription is issued if appropriate
• Medication is sent through a pharmacy
• Follow-up may be recommended

ZEPBOUND (tirzepatide) Prescribing Information - FDA-approved label including indications, dosing, warnings, and safety information. / Source: FDA Link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217806s003lbl.pdf / Published: November 8, 2023

ZEPBOUND (tirzepatide) injection - complete drug label with contraindications, warnings, and medication guide. / Source: DailyMed (NIH) Link: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b / Published: February 2026